Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Accendra Health, Inc. reported revenue of $2.76B, up 3.1% year over year. Operating margin was 1.0% and net margin -39.8%, on a free-cash-flow margin of -11.0% with capital expenditure at 7.3% of revenue. Every figure is computed directly from ACH's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.76B | 1.0% | -39.8% |
| FY2024 | $2.68B | -8.1% | -13.5% |
| FY2023 | $2.55B | 5.2% | -1.6% |
| FY2022 | $9.96B | 1.4% | 0.2% |
| FY2021 | $9.79B | 3.8% | 2.3% |
How does ACH compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 23 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: MCK · COR · CAH · SYY · PFGC · SNX
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.